• Search
  • Helpdesk
  • Sales contact

eCOA in ophthalmology

Last updated: June 24, 2024

There is an extended use of Patient Reported Outcome (PRO) measures in clinical trials used to assess health-related quality of life, symptoms, or perception of health status by the patients participating in clinical research. These measures are increasingly being collected via electronic devices and are, as such, referred to as ePROs.

In ophthalmology trials, the types of ePRO used can be general (SF-36, EQ-5D), vision specific (VFQ-25) or condition specific (glaucoma utility index, Retinopathy Treatment Satisfaction Questionnaire). A very wide range of validated questionnaires are available for use in research and selecting the right ePRO in an ophthalmology study is paramount to the success of a clinical trial.


Discover the five keys for successful ePRO selection in your ophthalmology clinical trial:

Follow us on LinkedIn to stay up-to-date on our latest videos:

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

ACDM 2026

MAR 15-17 2026 • Berlin, Germany
Booth #22 ACDM26 15-17 March 2026

C-PATH 2026

APR 16-17 2026 • Washington, D.C. USA

2026 Precision in Clinical Trials

APR 30 - MAY 1 2026 • Boston, MA, USA
Booth #3 Precision In Clinical Trials Summit | April 30 - May 1 - Boston

OCT Europe 2026

MAY 6-7 2026 • Barcelona, Spain
Booth #59 16th Annual Outsourcing in Clinical Trials Europe 2026 - Arena International

OCT East Coast 2026

MAY 12-13 2026 • New Brunswick, NJ, USA
Booth #7 17th Annual Outsourcing in Clinical Trials East Coast 2026 - Arena International

Patients as Partners 2026

MAY 19-20 2026 • London, UK
Patients as Partners EU

PCMG 2026

JUNE 16-17 2026 • Berlin, Germany
Register For PCMG26 Updates - PCMG 2026 Annual Assembly